AR and breast cancer: In conclusion, we performed genomewide PGx-eQTL analysis using agonists and antagonists of AR and identified DHT or Enz – AR regulated genes that are potentially influential in the endocrine therapy of breast cancer, genes and SNPs that could potentially serve as biomarkers for individualized endocrine therapy of breast cancer.